Personalized nutrition is one of the most up to date trends in human nutrition and gains much interest of general public and scientists as well. Although we have gained some knowledge on gene-trait associations, the real effectiveness and usefulness of genotype-based nutritional recommendations is unknown. Many personalized nutrition companies are on the market today, some of them use personalized nutrition based on genotype analysis. For this reason, scientific basis of this approach should be clarified. Our project can thus increase knowledge which can be applied in dietary counseling practice. Although we focus on increase vegetable and fruits intake, the study is designed as a proof of concept.
In humans, the TAS2R38 receptor gene is responsible for differences in the perception of bitter taste. This gene codes for a G protein that is associated with a flavor receptor regulated by phenylthiocarbamide (PTC) and propylthiouracil (PROP) ligands, which by binding to the receptor determines the degree of bitter taste. Cruciferous vegetables contain glucosinolates and isothiocyanates, which resemble PTC and PROP and thereby affect their perception of bitter taste through the TAS2R38 regulated receptor. The polymorphism of this gene allows to distinguish three phenotypes: * insensitive to bitter taste \[bitter-non tasters\] * moderately sensitive to bitter taste \[intermediate-bitter tasters\] * sensitive to bitter taste \[bitter taster\] Previous studies have shown that people who are carriers of one PAV haplotype experience a bitter taste more than AVI / AVI homozygotes, which are less sensitive to bitter taste. Hence, the TAS2R38 gene polymorphism is associated with nutritional decisions, including choice of vegetables and coffee. Aim of the study is to verify effectiveness of the genotype based dietary intervention in people with or without polymorphism of TAS2R38 gene.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Enrollment
174
Participants will receive personalized nutritional recommendations to increase fruit and vegetables consumption. Information about genotype will be given at the beginning of study
Participants will receive genotype personalized nutritional recommendations to increase fruit and vegetables consumption. Information about genotype will be given at the end of study
Participants will receive general nutritional recommendations to increase fruit and vegetables consumption
Poznan University of Life Sciences
Poznan, Poland
Vegetables intake
Change in frequency of vegatables intake within the group and between the groups; Block vegetables intake screener
Time frame: Baseline, 20 weeks
TAS2R38 polymorphism
genotyping of polymorphism TAS2R38 gene (rsr713598, rs1726866, and rs10246939)
Time frame: baseline
Body Mass (BM)
change in body mass (kg) within the group and between the groups
Time frame: Baseline, 20 weeks
Fat free mass (FFM)
change in FFM (kg) within the group and between the groups
Time frame: Baseline, 20 weeks
Fat Mass (FM) %
change in Fat Mass % within the group and between the groups
Time frame: Baseline, 20 weeks
Waist circumference (WC)
Change in WC (cm) within the group and between the groups
Time frame: Baseline, 20 weeks
Total Cholesterol (TChol)
Changes in TChol (mg/dl) within the group and between the groups
Time frame: Baseline, 20 weeks
LDL Cholesterol(LDL-Chol)
Changes in LDL-Chol (mg/dl) within the group and between the groups
Time frame: Baseline, 20 weeks
HDL Cholesterol (HDL-Chol)
Changes in HDL-Chol (mg/dl) within the group and between the groups
Time frame: Baseline, 20 weeks
Triglycerides (TG)
Changes in TG (mg/dl) within groups and between groups
Time frame: Baseline, 20 week
Glucose (GLU)
Changes in GLU (mg/dl) within the group and between the groups
Time frame: Baseline, 20 weeks
Insulin (INS)
Changes in INS (ulU/ml) within the group and between the groups
Time frame: Baseline, 20 weeks
Alanine transaminase (ALAT)
Changes in ALAT (U/l) within the group and between the groups
Time frame: Baseline, 20 weeks
aspartate aminotransferase (ASPAT)
Changes in ASPAT (U/l) within the group and between the groups
Time frame: Baseline, 20 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.